Butein, a Specific Protein Tyrosine Kinase Inhibitor
- 17 April 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 245 (2) , 435-438
- https://doi.org/10.1006/bbrc.1998.8452
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- STRUCTURE‐ACTIVITY RELATIONSHIPS FOR 4‐ANILINOQUINAZOLINES AS POTENT INHIBITORS AT THE ATP BINDING SITE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN VITROClinical and Experimental Pharmacology and Physiology, 1996
- Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolinesBreast Cancer Research and Treatment, 1996
- Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1996
- 4-(Phenylamino)pyrrolopyrimidines: Potent and Selective, ATP Site Directed Inhibitors of the EGF-Receptor Protein Tyrosine KinaseJournal of Medicinal Chemistry, 1996
- Site-Specific Association of c-SRC with Epidermal Growth Factor Receptor in A431 CellsBiochemical and Biophysical Research Communications, 1995
- Protein kinases in human breast cancerBreast Cancer Research and Treatment, 1995
- Involvement of pp60c-src with two major signaling pathways in human breast cancer.Proceedings of the National Academy of Sciences, 1994
- EGF receptor expression, regulation, and function in breast cancerBreast Cancer Research and Treatment, 1994
- Association between the PDGF receptor and members of the src family of tyrosine kinasesCell, 1990
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990